(Q39813821)

English

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib

scientific article

Statements

Antitumor efficacy of IPI-504, a selective heat shock protein 90 inhibitor against human epidermal growth factor receptor 2-positive human xenograft models as a single agent and in combination with trastuzumab or lapatinib (English)
Ching Ching Leow
Jon Chesebrough
Karen T Coffman
Christine A Fazenbaker
John Gooya
David Weng
Steve Coats
Dowdy Jackson
Bahija Jallal
Yong Chang
11 August 2009
2131-2141

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit